Events

The Second World Congress on Racial and Ethnic Health Disparities

The Second World Congress on Racial and Ethnic Health Disparities
January 27, 2026, to January 31, 2026

Springer Nature’s The Journal of Racial and Ethnic Health Disparities and the Connecticut National Medical Association (CTNMA) in conjunction with the National Medical Association (NMA), St. Lucia Medical and Dental Association, W. Montague Cobb /NMA Health Institute, the University of Connecticut, The Saint Lucia Academy of Science, Technology, and the Arts, and the Government of St. Lucia will host The Second World Congress on Racial and Ethnic Health Disparities in St. Lucia from January 27, 2026, to January 31, 2026.

The intent of this hybrid event is to encourage professionals to come together to discuss racial and ethnic health disparities and how to overcome them.

Springer Nature’s The Journal of Racial and Ethnic Health Disparities reports on the scholarly progress of work to understand, address, and ultimately eliminate health disparities based on race and ethnicity. Efforts to explore underlying causes of health disparities and to describe interventions that have been undertaken to address racial and ethnic health disparities are featured.

The Imhotep Connecticut National Medical Association Society (CTNMA) is an affiliate of the National Medical Association which represents “a collective voice of African American physicians and the leading force for parity and justice in medicine and the elimination of disparities in health.”

This is a Hybrid event, which comprises both in-person and virtual components.

The Second World Congress on Racial and Ethnic Health Disparities

Event Website

World Congress 2026 Program Brochure

American Chemical Society Holds Symposium in Honor of University Professor Cato T. Laurencin

On March 19, the American Chemical Society held the Kathryn C. Hach Award for Entrepreneurial Success Symposium in honor of Dr. Cato T. Laurencin, who is the University Professor, Albert and Wilda Van Dusen Distinguished Professor of Orthopaedic Surgery, and chief executive officer of The Cato T. Laurencin Institute for Regenerative Engineering at the University of Connecticut. Read more on UConn Today.

The Cato T. Laurencin Institute Launched at UConn

Dr. Cato Laurencin
A celebratory reception for the new Laurencin Institute was held on February 24 at UConn School of Medicine in Farmington.

We are excited to announce a new institute. It is entitled The Cato T. Laurencin Institute for Regenerative Engineering. “This initiative is only one of the countless number of Dr. Laurencin’s contributions to the development of science and engineering”, says Provost Anne D’Alleva.

Regenerative engineering is a field founded by Professor Cato T. Laurencin. It is described as the convergence of advanced materials sciences, stems cell science, physics, developmental biology, and clinical translation for the regeneration of complex tissues and organ systems. The Cato T. Laurencin Institute for Regenerative Engineering represents a transdisciplinary effort at UConn with a focus on the musculoskeletal area. The Institute integrates medicine, engineering, surgery, biology, physics, chemistry, and statistics/machine learning to enable a powerful platform for addressing scientific and medical problems in the regeneration and healing of complex tissues, organs, or organ systems.

The Cato T. Laurencin Institute of Regenerative Engineering holds to the pillars developed for the first Cato T. Laurencin Institute, namely:

Excellence in Science

Anti-Racism and Justice

Sponsorship and Mentorship

International, National, and Community Action

Transformative Technologies for Humanity

Economic Value Creation

In addition to this endeavor, Dr. Laurencin has created a ground-breaking project. It is entitled, Cato T. Laurencin Innovative Convergence Ventures (CTLICV). The CTLICV invests in next-generation companies based on innovative research conducted created within the Institute and its collaborating partners across UConn and greater university and corporate communities. We seek strong co-investor syndicates to develop products across a range of categories including regenerative engineering, drugs, devices, diagnostics, and digital health. The intent is to fast-track innovative research from bench to bed, with measurable impact on public health, quality of life, reducing societal disparity, and economic development.

CTLICV’s investments are directed at the seed and Series A stages, where it attracts capital and talent into the most difficult-to-fund phase of company development. When we invest, we expect to support each portfolio company through its entire financing lifecycle. We leverage the portfolio investment activity and internal/external relationships to further the mission vision and values of the Institute. Additionally, the fund taps into our experience in starting and growing companies, our expertise in the medical industry, and our network of scientific and business talent to build great companies.

The scientific and educational opportunities being pursued now and in the future at UConn will enable innovation and problem-solving beyond conventional academic boundaries. A core mission of UConn is precisely to foster new ways of thinking and new approaches to answers in medicine, science, engineering, and technology. We invite you to engage with us as we continue our work here at UConn.

The Cato T. Laurencin Institute for Regenerative Engineering
New Institute Logo

Dr. Cato Laurencin Receives Shu Chien Achievement Award

UConn Professor Dr. Cato T. Laurencin was honored last week at the Biomedical Engineering Society (BMES) Cellular and Molecular Bioengineering (CMBE)  conference. He was awarded the Shu Chien Achievement Award, the most prestigious honor bestowed by the BMES Cellular and Molecular Bioengineering (CMBE) Group. The award recognizes an individual who has made exceptional contributions to the cellular and molecular bioengineering field, and someone who has been a great mentor to others.

Read the full article here: https://today.uconn.edu/2023/01/dr-cato-laurencin-receives-shu-chien-achievement-award/

 

Dr. Cato T. Laurencin receives the Founders’ Award

The American Institute of Chemical Engineers Foundation (AIChE) and the AIChE Regenerative Engineering Society has established an award in honor of the society’s founder. The Cato T. Laurencin, Regenerative Engineering Founders’ Award, will recognize the accomplishments of individuals who have demonstrated leadership in the science and practice of convergence research as applied to regenerative engineering — a field pioneered by Dr. Cato T. Laurencin, the RE Society’s Founder. He received the American Institute of Chemical Engineers’ Founder’s Award this year at the AICHE annual meeting on November 14. The inaugural award will be presented in 2023 at the Regenerative Engineering Society’s Annual Meeting.

The award consists of a struck medal and an honorarium.

Laurencin, who is internationally renowned for his work in biomaterials, stem cell science, nanotechnology, drug delivery systems, as well the new field of regenerative engineering, serves as the chief executive officer of the Connecticut Convergence Institute for Translation in Regenerative Engineering Laurencin is the first surgeon in history to be elected to all four national academies: the National Academy of Sciences, the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors. He is the first person in history to receive the oldest/highest award of the National Academy of Medicine (the Walsh McDermott Medal) and the oldest/highest award of the National Academy of Engineering (the Simon Ramo Founder’s Award). In science, he received the Philip Hauge Abelson Prize given “for signal contributions to the advancement of science in the United States.

The field of regenerative engineering involves the convergence of advanced materials sciences, stem cell science, physics, developmental biology, and clinical translation to regenerate complex tissues and organ systems. The Cato T. Laurencin Regenerative Engineering Society Founders’ Award will be presented to distinguished researchers, innovators, mentors, and teachers who have furthered the goals of this field. Nominations for the inaugural prize are due on April 15, 2023.